Yael Mosse
Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania · Children's Hospital of Philadelphia
Credentials: · ·
History
Smith College Northampton, MA
Research
Identification of ALK as a major familial neuroblastoma predisposition gene
Nature · 2008 · First of 22 authors · 1,041 citations
The genetic landscape of high-risk neuroblastoma
Nature Genetics · 2013 · 953 citations
The Lancet Oncology · 2013 · First of 14 authors · Corresponding · 567 citations
66 papers
- EA
14 papers · 2 as a fellow
14 papers · 6 as a fellow
13 papers
13 papers
12 papers
- MS
12 papers
- DF
9 papers · 8 as a resident
Grants
- 2017–2029
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
National Cancer Institute · P01
Project lead · $2.7M · Children's Hosp of Philadelphia
- 2021–2027
NCI Pediatric In Vivo Testing Program: Neuroblastoma
National Cancer Institute · U01
Contact PI · $3.5M · Children's Hosp of Philadelphia
- 2009–2025
Targeting Oncogenic ALK Signaling in Neuroblastoma
National Cancer Institute · R01
Contact PI · $5.6M · Children's Hosp of Philadelphia
- 2005–2010
Genomics of Human Neuroblastoma
National Cancer Institute · K08
Contact PI · $682.1K · Children's Hosp of Philadelphia
Clinical trials
- 2016–2022
Next Generation Personalized Neuroblastoma Therapy
Principal investigator · Terminated · Phase 1
Yael P Mosse
- 2011–2019
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Principal investigator · Completed · Phase 2
Children's Oncology Group
- 2009–2018
Principal investigator · Completed · Phase 1, Phase 2
Children's Oncology Group
- 2017–2025
NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
Study chair · Completed · Phase 1
New Approaches to Neuroblastoma Therapy Consortium